RELATIONSHIP BETWEEN AREA OF SEROSAL INVASION AND INTRAPERITONEAL FREE CANCER-CELLS IN PATIENTS WITH GASTRIC-CANCER

被引:2
作者
IKEGUCHI, M
OKA, A
TSUJITANI, S
MAETA, M
KAIBARA, N
机构
关键词
ADVANCED GASTRIC CANCER; INTRAPERITONEAL FREE CANCER CELLS; MACROSCOPIC AREA OF SEROSAL INVASION BY TUMOR; INTRAPERITONEAL CHEMOTHERAPY;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This study, we evaluated the relationship between the macroscopic area of serosal invasion by gastric carcinoma and the incidence of intraperitoneal free cancer cells which were detected by lavage of the Douglas cavity. Between 1976 and 1989, 362 patients with advanced gastric cancel (t(3), t(4)) were gastrectomized and intraperitoneal free cancer cells were recognized in 119 patients (32.9%). Only 17.3% of patients with an area of serosal invasion of less than 10 cm(2) had ee cancer cells in their peritoneal cavities, however; 68.5% of patients with an area of serosal invasion greater than 20 cm(2) had free cancer cells. Even, if curative surgery was performed for patients with free cancer cells, their five-year survival rate was very poor. The five-year survival rate of patients with curatively operated gastric cancer without free cancer cells was 49.3%, however that of patients with free cancer cells was significantly lower (15.4%, P<0.01). Even when we are not able to receive the cytologic diagnosis for intraperitoneal free cancer cells during the operation, patients with macroscopic areas of serosal invasion greater than 20 cm(2) may have free cancer cells in a very high percentage. They should be treated with effective adjuvant chemotherapy the soon after the operation to prevent peritoneal metastatic recurrence and to prolong survival.
引用
收藏
页码:2131 / 2134
页数:4
相关论文
共 16 条
[1]   NORWEGIAN MULTICENTER STUDY OF SURVIVAL AND PROGNOSTIC FACTORS IN PATIENTS UNDERGOING CURATIVE RESECTION FOR GASTRIC-CARCINOMA [J].
HAUGSTVEDT, TK ;
VISTE, A ;
EIDE, GE ;
SOREIDE, O .
BRITISH JOURNAL OF SURGERY, 1993, 80 (04) :475-478
[2]  
IITSUKA Y, 1979, CANCER, V44, P1476, DOI 10.1002/1097-0142(197910)44:4<1476::AID-CNCR2820440442>3.0.CO
[3]  
2-R
[4]  
IITSUKA Y, 1990, ACTA CYTOL, V34, P437
[5]  
KAIBARA N, 1989, HEPATO-GASTROENTEROL, V36, P75
[6]  
MING SC, 1977, CANCER, V39, P2475, DOI 10.1002/1097-0142(197706)39:6<2475::AID-CNCR2820390626>3.0.CO
[7]  
2-L
[8]  
MOORE GE, 1961, SURG GYNECOL OBSTET, V112, P469
[9]  
NAKAJIMA T, 1978, Acta Cytologica, V22, P225
[10]  
NAKAMURA K, 1992, CANCER, V70, P1030, DOI 10.1002/1097-0142(19920901)70:5&lt